About TARGAN
TARGAN is an Agriculture company based in Morrisville (United States) founded in 2015 by Ramin Karimpour. Automated targeted vaccine systems for livestock and aquaculture are developed. TARGAN has raised $65.9 million across 6 funding rounds from investors including Merck Animal Health, Mountain Group Partners and NovaQuest Capital Management. The company has 29 employees. Its chief executive, as recorded, is Ramin Karimpour. Its focus areas include Food and Agriculture Tech, Livestock Tech, Health Management and Pharmaceuticals. Its legal entity is TARGAN Inc. Its competitors include Merck Animal Health and Harrisvaccines; 1 of its 2 listed competitors has raised funding.
Company details
Founded in 2015 and based in Morrisville, United States, automated targeted vaccine delivery systems are developed by the company for livestock and aquaculture sectors. Technologies including high-speed imaging, microfluidics, artificial intelligence, and humane animal handling are integrated to provide vaccination solutions that reduce infection-related losses. Solutions are offered for aquaculture, pigs, and poultry operations.
- Headquarters Morrisville, United States
- Employees 29
- Founders Ramin Karimpour
- SectorsAgriculture
- Email••••••••
- Phone•••• ••••
- Website targan.com
- Social LinkedIn X Instagram
- Legal Name Targan Inc.
- Total Equity Funding$65.9M (USD)
in 6 rounds
- Latest Funding Round$35M (USD), Series C
May 2022
- InvestorsMerck Animal Health
& 4 more
- Employee Count29
Funding Insights of TARGAN
TARGAN has successfully raised a total of $65.9M across 6 strategic funding rounds. The most recent funding activity was a Series C round of $35 million completed in May 2022. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $65.9M
- Total Rounds 6
- Last Round Series C — $35M
- First Round $1.41M
(Feb 2018)
- Investors Count 5
All 6 funding rounds of TARGAN with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| May 2022 | $35M | Series C | – | Mountain Group Partners, NovaQuest Capital Management | |
| May 2021 | $7M | Series B | – | Mountain Group Partners, Merck Animal Health | |
| May 2021 | $7M | Series B | – | – | |
| Mar 2019 | $8M | Series A | – | Merck Animal Health, Mountain Group Partners | |
| Mar 2019 | $8.9M | Series A | – | – | |
| Feb 2018 | $1.41M | Grant | – | – |
5 investors in total: 5 institutional.
Investors in TARGAN
TARGAN has secured backing from 5 investors, including venture fund and institutional investors. Prominent investors backing the company include Merck Animal Health, Mountain Group Partners and NovaQuest Capital Management.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Venture capital is directed toward life sciences and technology sectors. | mtngp.com | Nashville, United States | ||
PE firm focused on life science and healthcare companies | novaquest.com | Raleigh, United States | ||
Early-stage venture capital investments are provided by Oval Park Capital. | ovalpark.com | Raleigh, United States | ||
Vaccine technology is developed and supplied for livestock animals. | 1921 | merck-animal-health.com | Madison, United States | |
A government-backed foundation providing seed-stage investments to support small businesses. | 1950 | nsf.gov | Arlington, United States |
Investor details for TARGAN
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of TARGAN
36 people are tracked at TARGAN (7 in leadership, 6 in board & advisors, 23 in team); the tracked headcount is 29.
| Name | Role | Group |
|---|---|---|
Ramin Karimpour | Founder & CEO | Leadership |
Nicolas Massie | Director, Program Management, Poultry | Leadership |
Chris Thomas | Director Of Controls And Electrical Engineering | Leadership |
Paul Burke | Senior Director Human Resources | Leadership |
Zebulon Rouse | Director Of Mechanical Engineering | Leadership |
Matt Mekschun | Director of Controls and Computer Vision Engineering | Leadership |
Joshua Goff | Director, Vision AI & Data Science | Leadership |
John Roush | Director | Board & advisors |
Rob Readnour | Director | Board & advisors |
Clinton A. Lewis | Director | Board & advisors |
Mike Roberts | Director | Board & advisors |
Taylor Barbosa | Director | Board & advisors |
Brian Axe | Director | Board & advisors |
Jason Fryar | Customer Success Manager | Team |
Fredrick Hutchinson | Senior Recruiter - TARGAN, Inc | Team |
Sanat Aryal | Auzure Support Engineer III | Team |
Evan Trebilcock | Senior Manager Product Engineering | Team |
Joseph Strahl | Business Process Lead | Team |
Terry Stanfield | Senior Software Engineer | Team |
Rafael Luiz da Silva, Ph.D. | Sr. Computer Vision Engineer | Team |
16 more people are available in the full profile.
Complete people profiles for TARGAN
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of TARGAN
3 dated milestones of TARGAN across 7 years, from founding to its latest funding, stage changes and deals.
- Founded TARGAN is founded.
- Funding First funding round of $1.4M.
- Funding Latest funding round, Series C, of $35.0M.
Competitors of TARGAN
TARGAN has 2 listed competitors in our database, 1 of them funded. They include Merck Animal Health and Harrisvaccines.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| merck-animal-health.com | 1921 | Madison, United States | 2,952 | Vaccine technology is developed and supplied for livestock animals. | ||
| harrisvaccines.com | 2005 | Ames, United States | $5M | Developer of vaccine technology for the treatment of infectious diseases |
Detailed competitors of TARGAN
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of TARGAN
The website of TARGAN (targan.com) receives about 1.6K visits a month.
- Monthly visits1.6K
▼ 23.9% vs previous month
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Targan
Complete news archive for TARGAN
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about TARGAN
TARGAN was founded in 2015 and raised its 1st funding round 3 years after it was founded.
TARGAN is headquartered in Morrisville, United States.
Ramin Karimpour is the CEO of TARGAN, as recorded in our data. They have also founded this company.
TARGAN is a funded company, having raised a total of $65.9M across 6 funding rounds to date. The company's 1st funding round was a Grant of $1.41M, raised on Feb 2018.
TARGAN has 29 employees.
Founded in 2015 and based in Morrisville, United States, automated targeted vaccine delivery systems are developed by the company for livestock and aquaculture sectors. Technologies including high-speed imaging, microfluidics, artificial intelligence, and humane animal handling are integrated to provide vaccination solutions that reduce infection-related losses. Solutions are offered for aquaculture, pigs, and poultry operations.
TARGAN's top competitors include Merck Animal Health and Harrisvaccines.
TARGAN has 5 investors. Key investors include Merck Animal Health, Mountain Group Partners, NovaQuest Capital Management, Oval Park Capital, and National Science Foundation.
TARGAN operates through Targan Inc..